

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 6.70489545 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 6.56749117 |
| 3 | translational termination (GO:0006415) | 6.34447690 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 6.02912129 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.76908267 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 5.70741976 |
| 7 | protein targeting to ER (GO:0045047) | 5.68246202 |
| 8 | protein localization to endoplasmic reticulum (GO:0070972) | 5.40140963 |
| 9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.35663226 |
| 10 | omega-hydroxylase P450 pathway (GO:0097267) | 5.34206206 |
| 11 | translational elongation (GO:0006414) | 5.04530624 |
| 12 | nucleotide salvage (GO:0043173) | 4.91176328 |
| 13 | viral life cycle (GO:0019058) | 4.86923285 |
| 14 | cellular protein complex disassembly (GO:0043624) | 4.63087870 |
| 15 | ribosomal large subunit biogenesis (GO:0042273) | 4.57276179 |
| 16 | proteasome assembly (GO:0043248) | 4.53591095 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.34427857 |
| 18 | purine nucleotide salvage (GO:0032261) | 4.34199570 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 4.22918950 |
| 20 | DNA deamination (GO:0045006) | 4.18378761 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.17822240 |
| 22 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.13166320 |
| 23 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.13166320 |
| 24 | translational initiation (GO:0006413) | 4.07573626 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 3.85979308 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.85979308 |
| 27 | protein complex disassembly (GO:0043241) | 3.81523772 |
| 28 | short-term memory (GO:0007614) | 3.77544059 |
| 29 | nucleoside salvage (GO:0043174) | 3.76015479 |
| 30 | amino sugar catabolic process (GO:0046348) | 3.71813461 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 3.65590113 |
| 32 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.62562362 |
| 33 | protein targeting to membrane (GO:0006612) | 3.62484709 |
| 34 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.59494541 |
| 35 | termination of RNA polymerase III transcription (GO:0006386) | 3.59494541 |
| 36 | macromolecular complex disassembly (GO:0032984) | 3.58392078 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.58136338 |
| 38 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.56617115 |
| 39 | endothelium development (GO:0003158) | 3.56494767 |
| 40 | mesonephros development (GO:0001823) | 3.55483741 |
| 41 | translation (GO:0006412) | 3.49035972 |
| 42 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.41627230 |
| 43 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.39573831 |
| 44 | protein heterotetramerization (GO:0051290) | 3.36071471 |
| 45 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.30688497 |
| 46 | GTP biosynthetic process (GO:0006183) | 3.28444288 |
| 47 | pentose metabolic process (GO:0019321) | 3.27699020 |
| 48 | pyrimidine-containing compound salvage (GO:0008655) | 3.22581384 |
| 49 | pyrimidine nucleoside salvage (GO:0043097) | 3.22581384 |
| 50 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.21634039 |
| 51 | xenobiotic catabolic process (GO:0042178) | 3.20358785 |
| 52 | ATP synthesis coupled proton transport (GO:0015986) | 3.20328061 |
| 53 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.20328061 |
| 54 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.16364808 |
| 55 | drug catabolic process (GO:0042737) | 3.13753512 |
| 56 | deoxyribonucleotide catabolic process (GO:0009264) | 3.12270609 |
| 57 | pattern specification involved in kidney development (GO:0061004) | 3.09870585 |
| 58 | exogenous drug catabolic process (GO:0042738) | 3.08993587 |
| 59 | regulation of plasminogen activation (GO:0010755) | 3.06037646 |
| 60 | respiratory electron transport chain (GO:0022904) | 3.05803464 |
| 61 | lymphoid progenitor cell differentiation (GO:0002320) | 3.04256740 |
| 62 | electron transport chain (GO:0022900) | 3.03370198 |
| 63 | deoxyribose phosphate catabolic process (GO:0046386) | 3.02068090 |
| 64 | signal peptide processing (GO:0006465) | 3.01639555 |
| 65 | epoxygenase P450 pathway (GO:0019373) | 3.01433139 |
| 66 | cellular metabolic compound salvage (GO:0043094) | 2.99902801 |
| 67 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.97635057 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 2.97133665 |
| 69 | sulfur amino acid catabolic process (GO:0000098) | 2.96940373 |
| 70 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.94851654 |
| 71 | doxorubicin metabolic process (GO:0044598) | 2.94822976 |
| 72 | daunorubicin metabolic process (GO:0044597) | 2.94822976 |
| 73 | polyketide metabolic process (GO:0030638) | 2.94822976 |
| 74 | positive regulation of prostaglandin secretion (GO:0032308) | 2.93262728 |
| 75 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.93013587 |
| 76 | phenylpropanoid metabolic process (GO:0009698) | 2.92904428 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92483662 |
| 78 | N-acetylneuraminate metabolic process (GO:0006054) | 2.91381743 |
| 79 | cytochrome complex assembly (GO:0017004) | 2.91050125 |
| 80 | aromatic amino acid family catabolic process (GO:0009074) | 2.88448180 |
| 81 | mRNA catabolic process (GO:0006402) | 2.87200876 |
| 82 | L-serine metabolic process (GO:0006563) | 2.83642674 |
| 83 | blood coagulation, intrinsic pathway (GO:0007597) | 2.83583857 |
| 84 | glucosamine-containing compound catabolic process (GO:1901072) | 2.81339681 |
| 85 | androgen biosynthetic process (GO:0006702) | 2.80718544 |
| 86 | complement activation, alternative pathway (GO:0006957) | 2.77808381 |
| 87 | aldehyde catabolic process (GO:0046185) | 2.77392318 |
| 88 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.76229955 |
| 89 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.75231256 |
| 90 | facial nerve structural organization (GO:0021612) | 2.74069421 |
| 91 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.73124833 |
| 92 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.71056446 |
| 93 | galactose catabolic process (GO:0019388) | 2.70161178 |
| 94 | UTP biosynthetic process (GO:0006228) | 2.68486949 |
| 95 | regulation of interleukin-8 secretion (GO:2000482) | 2.65694134 |
| 96 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.65205008 |
| 97 | positive regulation of icosanoid secretion (GO:0032305) | 2.64428757 |
| 98 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.64014572 |
| 99 | postsynaptic membrane organization (GO:0001941) | 2.63576352 |
| 100 | positive regulation of chemokine secretion (GO:0090197) | 2.63274171 |
| 101 | ethanol oxidation (GO:0006069) | 2.62611312 |
| 102 | central nervous system myelination (GO:0022010) | 2.60913370 |
| 103 | axon ensheathment in central nervous system (GO:0032291) | 2.60913370 |
| 104 | glycine metabolic process (GO:0006544) | 2.60604746 |
| 105 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.59896967 |
| 106 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.59896967 |
| 107 | bile acid biosynthetic process (GO:0006699) | 2.59850531 |
| 108 | purine-containing compound salvage (GO:0043101) | 2.59819144 |
| 109 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.58830069 |
| 110 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.58318422 |
| 111 | branched-chain amino acid catabolic process (GO:0009083) | 2.57696318 |
| 112 | drug metabolic process (GO:0017144) | 2.57691208 |
| 113 | GPI anchor biosynthetic process (GO:0006506) | 2.57466550 |
| 114 | cellular component biogenesis (GO:0044085) | 2.56337342 |
| 115 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.56008875 |
| 116 | L-methionine salvage (GO:0071267) | 2.55821753 |
| 117 | L-methionine biosynthetic process (GO:0071265) | 2.55821753 |
| 118 | amino acid salvage (GO:0043102) | 2.55821753 |
| 119 | regulation of triglyceride catabolic process (GO:0010896) | 2.55714985 |
| 120 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.55576580 |
| 121 | RNA catabolic process (GO:0006401) | 2.54785651 |
| 122 | regulation of development, heterochronic (GO:0040034) | 2.54422573 |
| 123 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.53840617 |
| 124 | base-excision repair, AP site formation (GO:0006285) | 2.52993452 |
| 125 | regulation of metalloenzyme activity (GO:0048552) | 2.52315477 |
| 126 | platelet dense granule organization (GO:0060155) | 2.51661675 |
| 127 | phospholipid efflux (GO:0033700) | 2.49768958 |
| 128 | serine family amino acid metabolic process (GO:0009069) | 2.49068568 |
| 129 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.48985930 |
| 130 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.48870450 |
| 131 | deoxyribose phosphate metabolic process (GO:0019692) | 2.48842037 |
| 132 | mature B cell differentiation involved in immune response (GO:0002313) | 2.45561210 |
| 133 | regulation of timing of cell differentiation (GO:0048505) | 2.44666007 |
| 134 | DNA damage response, detection of DNA damage (GO:0042769) | 2.44110374 |
| 135 | regulation of pigment cell differentiation (GO:0050932) | 2.43500816 |
| 136 | glutathione derivative metabolic process (GO:1901685) | 2.43432296 |
| 137 | presynaptic membrane assembly (GO:0097105) | 2.43294544 |
| 138 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.41017088 |
| 139 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.41017088 |
| 140 | CTP biosynthetic process (GO:0006241) | 2.38922599 |
| 141 | CTP metabolic process (GO:0046036) | 2.38922599 |
| 142 | mature B cell differentiation (GO:0002335) | 2.37733714 |
| 143 | GMP metabolic process (GO:0046037) | 2.36469775 |
| 144 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.35367210 |
| 145 | positive regulation of protein kinase C signaling (GO:0090037) | 2.35243660 |
| 146 | mesenchymal to epithelial transition (GO:0060231) | 2.35172493 |
| 147 | protein complex biogenesis (GO:0070271) | 2.34694845 |
| 148 | establishment of protein localization to membrane (GO:0090150) | 2.33432890 |
| 149 | response to hyperoxia (GO:0055093) | 2.32300052 |
| 150 | response to increased oxygen levels (GO:0036296) | 2.32300052 |
| 151 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.32109546 |
| 152 | NADH dehydrogenase complex assembly (GO:0010257) | 2.32109546 |
| 153 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.32109546 |
| 154 | tRNA modification (GO:0006400) | 2.29720441 |
| 155 | rRNA processing (GO:0006364) | 2.29116440 |
| 156 | sphingoid metabolic process (GO:0046519) | 2.28824614 |
| 157 | response to interferon-beta (GO:0035456) | 2.28465835 |
| 158 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.27834667 |
| 159 | tRNA methylation (GO:0030488) | 2.27805982 |
| 160 | nephron epithelium development (GO:0072009) | 2.27739821 |
| 161 | UTP metabolic process (GO:0046051) | 2.26973212 |
| 162 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.26444850 |
| 163 | L-phenylalanine metabolic process (GO:0006558) | 2.26444850 |
| 164 | mannosylation (GO:0097502) | 2.26270579 |
| 165 | protein targeting (GO:0006605) | 2.25623607 |
| 166 | centriole assembly (GO:0098534) | 2.25143644 |
| 167 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.24277354 |
| 168 | limb bud formation (GO:0060174) | 2.24217059 |
| 169 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.22664254 |
| 170 | radial glial cell differentiation (GO:0060019) | 2.22194518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.86201371 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.25234642 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.68024551 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.55350421 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.54804096 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.45523040 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.31739254 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.04279111 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.99288240 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.96888069 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.85989391 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.58775935 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.58775935 |
| 14 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.58775935 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.40803588 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32544875 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.27893257 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.27292388 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.23459048 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.21367022 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20848932 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.16678698 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.11833646 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11491479 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.06124338 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99974978 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.95905619 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.92853151 |
| 29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.89536567 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87849045 |
| 31 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.87477846 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77250913 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77079865 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.73309083 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70803912 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70087713 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66464214 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.62449352 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55630549 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55567389 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55068460 |
| 42 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.53704227 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53479646 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49149746 |
| 45 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.48297860 |
| 46 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.48019788 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.47905487 |
| 48 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.47362291 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46367253 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.44820396 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44215855 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44053341 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43132342 |
| 54 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.42992439 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42307014 |
| 56 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.40586238 |
| 57 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.40484130 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40366724 |
| 59 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.38239241 |
| 60 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.38227360 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38008645 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37716755 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.37620647 |
| 64 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.36483919 |
| 65 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35965057 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35723985 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35651959 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34275207 |
| 69 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33755869 |
| 70 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33393302 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31920264 |
| 72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31610539 |
| 73 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31474643 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.30444869 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30085051 |
| 76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29231274 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.29221879 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27377269 |
| 79 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.27066670 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25833411 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25047225 |
| 82 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.23666534 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23167567 |
| 84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21247917 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20978321 |
| 86 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19905829 |
| 87 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19236930 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18628831 |
| 89 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16485962 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16306681 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16144918 |
| 92 | SA1_27219007_Chip-Seq_Bcells_Human | 1.15618106 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15207701 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.15095856 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14400460 |
| 96 | * P300_27268052_Chip-Seq_Bcells_Human | 1.13306563 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12925785 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12810281 |
| 99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12234918 |
| 100 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.12060336 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11544779 |
| 102 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11194052 |
| 103 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09898870 |
| 104 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09293163 |
| 105 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08931047 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08186259 |
| 107 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.08091775 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07861331 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07834789 |
| 110 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06797837 |
| 111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06595727 |
| 112 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06298170 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06054978 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06008908 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05942962 |
| 116 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05153445 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05109513 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04653804 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03994454 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03693603 |
| 121 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.03662630 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03355389 |
| 123 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.03249306 |
| 124 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03123159 |
| 125 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02707754 |
| 126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01949013 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 1.00313475 |
| 128 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99814441 |
| 129 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98974853 |
| 130 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.98907384 |
| 131 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98518380 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97997023 |
| 133 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97708984 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97664819 |
| 135 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97644801 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97594724 |
| 137 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97482434 |
| 138 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96829882 |
| 139 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96087276 |
| 140 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95774125 |
| 141 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.95762865 |
| 142 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93939081 |
| 143 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93859339 |
| 144 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.93667397 |
| 145 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93414954 |
| 146 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92441757 |
| 147 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91904525 |
| 148 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91290422 |
| 149 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89428496 |
| 150 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.89214559 |
| 151 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.88750649 |
| 152 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88054676 |
| 153 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86957950 |
| 154 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.85937042 |
| 155 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.85452789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 7.80637826 |
| 2 | MP0003136_yellow_coat_color | 5.25056954 |
| 3 | MP0004381_abnormal_hair_follicle | 3.75107365 |
| 4 | MP0001188_hyperpigmentation | 3.54940628 |
| 5 | MP0003724_increased_susceptibility_to | 3.49366883 |
| 6 | MP0005409_darkened_coat_color | 3.23836102 |
| 7 | MP0006292_abnormal_olfactory_placode | 2.85870645 |
| 8 | MP0003941_abnormal_skin_development | 2.83370537 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.82620501 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.55157163 |
| 11 | MP0005365_abnormal_bile_salt | 2.54462150 |
| 12 | MP0000566_synostosis | 2.33799787 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.29527558 |
| 14 | MP0009840_abnormal_foam_cell | 2.23697599 |
| 15 | MP0005332_abnormal_amino_acid | 2.05936369 |
| 16 | MP0003878_abnormal_ear_physiology | 2.04225354 |
| 17 | MP0005377_hearing/vestibular/ear_phenot | 2.04225354 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 1.94243994 |
| 19 | MP0000372_irregular_coat_pigmentation | 1.93019944 |
| 20 | MP0003252_abnormal_bile_duct | 1.91530481 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.85812168 |
| 22 | MP0003011_delayed_dark_adaptation | 1.85352381 |
| 23 | MP0002249_abnormal_larynx_morphology | 1.82151705 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.79597496 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.78789275 |
| 26 | MP0002102_abnormal_ear_morphology | 1.76240521 |
| 27 | MP0000015_abnormal_ear_pigmentation | 1.75385833 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.61490747 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.59819208 |
| 30 | MP0000049_abnormal_middle_ear | 1.58245335 |
| 31 | MP0005387_immune_system_phenotype | 1.55531674 |
| 32 | MP0001790_abnormal_immune_system | 1.55531674 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.51470494 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.45541001 |
| 35 | MP0008469_abnormal_protein_level | 1.45079296 |
| 36 | MP0000685_abnormal_immune_system | 1.43645544 |
| 37 | MP0002132_abnormal_respiratory_system | 1.42494592 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.39223589 |
| 39 | MP0003938_abnormal_ear_development | 1.37749290 |
| 40 | MP0002095_abnormal_skin_pigmentation | 1.37572622 |
| 41 | MP0005670_abnormal_white_adipose | 1.37146119 |
| 42 | MP0001800_abnormal_humoral_immune | 1.36870562 |
| 43 | MP0002163_abnormal_gland_morphology | 1.36733253 |
| 44 | MP0001919_abnormal_reproductive_system | 1.36423897 |
| 45 | MP0002723_abnormal_immune_serum | 1.35177087 |
| 46 | MP0003718_maternal_effect | 1.32812544 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.32371135 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.30880786 |
| 49 | MP0001542_abnormal_bone_strength | 1.30467578 |
| 50 | MP0000613_abnormal_salivary_gland | 1.30276320 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.29426490 |
| 52 | MP0009250_abnormal_appendicular_skeleto | 1.28788521 |
| 53 | MP0006082_CNS_inflammation | 1.27999232 |
| 54 | MP0002177_abnormal_outer_ear | 1.27534840 |
| 55 | MP0003186_abnormal_redox_activity | 1.26842826 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.25716383 |
| 57 | MP0002938_white_spotting | 1.24601754 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.23981467 |
| 59 | MP0005379_endocrine/exocrine_gland_phen | 1.23184777 |
| 60 | MP0003868_abnormal_feces_composition | 1.19714390 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.19462678 |
| 62 | MP0002254_reproductive_system_inflammat | 1.18630865 |
| 63 | MP0003828_pulmonary_edema | 1.16948322 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.16404677 |
| 65 | MP0003786_premature_aging | 1.15893859 |
| 66 | MP0005171_absent_coat_pigmentation | 1.14769119 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.14517562 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.11330612 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.11251376 |
| 70 | MP0009785_altered_susceptibility_to | 1.11102875 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.10643089 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.10528621 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.08791067 |
| 74 | MP0001819_abnormal_immune_cell | 1.08086136 |
| 75 | MP0002876_abnormal_thyroid_physiology | 1.07422826 |
| 76 | MP0001756_abnormal_urination | 1.06587931 |
| 77 | MP0000490_abnormal_crypts_of | 1.06573243 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 1.06517066 |
| 79 | MP0001661_extended_life_span | 1.06328201 |
| 80 | MP0005408_hypopigmentation | 1.05881916 |
| 81 | MP0003866_abnormal_defecation | 1.05230534 |
| 82 | MP0002009_preneoplasia | 1.04791447 |
| 83 | MP0000609_abnormal_liver_physiology | 1.03300951 |
| 84 | MP0005595_abnormal_vascular_smooth | 0.96377378 |
| 85 | MP0004147_increased_porphyrin_level | 0.96120276 |
| 86 | MP0009697_abnormal_copulation | 0.95998554 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94726088 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.91591355 |
| 89 | MP0001533_abnormal_skeleton_physiology | 0.90426984 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.89895486 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.89779811 |
| 92 | MP0005257_abnormal_intraocular_pressure | 0.89343457 |
| 93 | MP0008872_abnormal_physiological_respon | 0.89105928 |
| 94 | MP0002933_joint_inflammation | 0.88942243 |
| 95 | MP0001873_stomach_inflammation | 0.88391149 |
| 96 | MP0002638_abnormal_pupillary_reflex | 0.88373321 |
| 97 | MP0003195_calcinosis | 0.87942405 |
| 98 | MP0003763_abnormal_thymus_physiology | 0.87863122 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.87564935 |
| 100 | MP0003436_decreased_susceptibility_to | 0.87396939 |
| 101 | MP0003075_altered_response_to | 0.87368331 |
| 102 | MP0000467_abnormal_esophagus_morphology | 0.87288752 |
| 103 | MP0005646_abnormal_pituitary_gland | 0.87222183 |
| 104 | * MP0009763_increased_sensitivity_to | 0.87090475 |
| 105 | MP0005025_abnormal_response_to | 0.85084467 |
| 106 | MP0002160_abnormal_reproductive_system | 0.83805176 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 0.82723127 |
| 108 | MP0008932_abnormal_embryonic_tissue | 0.82062967 |
| 109 | MP0003303_peritoneal_inflammation | 0.81832460 |
| 110 | MP0005360_urolithiasis | 0.81360596 |
| 111 | MP0002098_abnormal_vibrissa_morphology | 0.81021061 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80794511 |
| 113 | MP0005671_abnormal_response_to | 0.80766697 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.79851511 |
| 115 | MP0005389_reproductive_system_phenotype | 0.79692874 |
| 116 | MP0000762_abnormal_tongue_morphology | 0.79642752 |
| 117 | MP0000716_abnormal_immune_system | 0.79313351 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.78907273 |
| 119 | MP0008995_early_reproductive_senescence | 0.78236140 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.78125822 |
| 121 | MP0001346_abnormal_lacrimal_gland | 0.77993707 |
| 122 | MP0010030_abnormal_orbit_morphology | 0.77973586 |
| 123 | MP0003880_abnormal_central_pattern | 0.77714366 |
| 124 | MP0008260_abnormal_autophagy | 0.77618419 |
| 125 | MP0002796_impaired_skin_barrier | 0.77513358 |
| 126 | MP0004142_abnormal_muscle_tone | 0.77512276 |
| 127 | MP0000343_altered_response_to | 0.76598793 |
| 128 | * MP0009642_abnormal_blood_homeostasis | 0.75403646 |
| 129 | MP0003879_abnormal_hair_cell | 0.75335914 |
| 130 | MP0002751_abnormal_autonomic_nervous | 0.75287856 |
| 131 | MP0000026_abnormal_inner_ear | 0.74818075 |
| 132 | MP0001853_heart_inflammation | 0.74547452 |
| 133 | MP0006035_abnormal_mitochondrial_morpho | 0.73586243 |
| 134 | MP0009764_decreased_sensitivity_to | 0.73455922 |
| 135 | MP0008058_abnormal_DNA_repair | 0.72788280 |
| 136 | MP0008789_abnormal_olfactory_epithelium | 0.71982169 |
| 137 | MP0003385_abnormal_body_wall | 0.71504735 |
| 138 | MP0002722_abnormal_immune_system | 0.70408006 |
| 139 | MP0004133_heterotaxia | 0.70314012 |
| 140 | MP0005000_abnormal_immune_tolerance | 0.68929575 |
| 141 | MP0002429_abnormal_blood_cell | 0.68163888 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.67746992 |
| 143 | MP0000465_gastrointestinal_hemorrhage | 0.67574249 |
| 144 | MP0002282_abnormal_trachea_morphology | 0.67319214 |
| 145 | MP0001243_abnormal_dermal_layer | 0.66093592 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.65863695 |
| 147 | MP0009053_abnormal_anal_canal | 0.65548951 |
| 148 | MP0001663_abnormal_digestive_system | 0.65470582 |
| 149 | MP0005451_abnormal_body_composition | 0.64927595 |
| 150 | MP0002419_abnormal_innate_immunity | 0.63368764 |
| 151 | MP0005501_abnormal_skin_physiology | 0.62710991 |
| 152 | MP0003315_abnormal_perineum_morphology | 0.61230456 |
| 153 | MP0003936_abnormal_reproductive_system | 0.61164486 |
| 154 | MP0000678_abnormal_parathyroid_gland | 0.60383061 |
| 155 | MP0001764_abnormal_homeostasis | 0.59861911 |
| 156 | MP0001286_abnormal_eye_development | 0.59518572 |
| 157 | MP0000579_abnormal_nail_morphology | 0.57845775 |
| 158 | MP0001984_abnormal_olfaction | 0.57570896 |
| 159 | MP0000631_abnormal_neuroendocrine_gland | 0.56988678 |
| 160 | MP0009765_abnormal_xenobiotic_induced | 0.56509576 |
| 161 | MP0001835_abnormal_antigen_presentation | 0.56124061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 4.38664146 |
| 2 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.95359721 |
| 3 | Reduced antithrombin III activity (HP:0001976) | 3.82754336 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 3.74942615 |
| 5 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.73839613 |
| 6 | 3-Methylglutaconic aciduria (HP:0003535) | 3.68891764 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.62121693 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.60490537 |
| 9 | Macrocytic anemia (HP:0001972) | 3.55162258 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 3.42928922 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.38149644 |
| 12 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.33058299 |
| 13 | Abnormality of the axillary hair (HP:0100134) | 3.29160781 |
| 14 | Abnormality of secondary sexual hair (HP:0009888) | 3.29160781 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.18890269 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 3.16910913 |
| 17 | Abnormal hemoglobin (HP:0011902) | 3.09029680 |
| 18 | Prolonged neonatal jaundice (HP:0006579) | 3.01618473 |
| 19 | Complement deficiency (HP:0004431) | 2.93020485 |
| 20 | Progressive macrocephaly (HP:0004481) | 2.92238451 |
| 21 | Concave nail (HP:0001598) | 2.90991107 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 2.89669440 |
| 23 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.84037609 |
| 24 | Dicarboxylic aciduria (HP:0003215) | 2.84037609 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.83321709 |
| 26 | Generalized aminoaciduria (HP:0002909) | 2.83041592 |
| 27 | Congenital, generalized hypertrichosis (HP:0004540) | 2.80979281 |
| 28 | Pallor (HP:0000980) | 2.77746640 |
| 29 | Dry hair (HP:0011359) | 2.67684282 |
| 30 | Hepatocellular necrosis (HP:0001404) | 2.67363121 |
| 31 | Exertional dyspnea (HP:0002875) | 2.65592661 |
| 32 | Parakeratosis (HP:0001036) | 2.63445270 |
| 33 | Abnormal sex determination (HP:0012244) | 2.62455570 |
| 34 | Sex reversal (HP:0012245) | 2.62455570 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.59171386 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.56589725 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.56589725 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.56589725 |
| 39 | Microvesicular hepatic steatosis (HP:0001414) | 2.54497846 |
| 40 | Cerebral palsy (HP:0100021) | 2.54194397 |
| 41 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.54105448 |
| 42 | Lactic acidosis (HP:0003128) | 2.51252711 |
| 43 | Abnormal pupillary function (HP:0007686) | 2.50156421 |
| 44 | Increased serum ferritin (HP:0003281) | 2.42317979 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.41504356 |
| 46 | Hepatic necrosis (HP:0002605) | 2.41141532 |
| 47 | Hyperammonemia (HP:0001987) | 2.38668861 |
| 48 | Abnormal protein glycosylation (HP:0012346) | 2.38517621 |
| 49 | Abnormal glycosylation (HP:0012345) | 2.38517621 |
| 50 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.38517621 |
| 51 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.38517621 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.37347279 |
| 53 | Triphalangeal thumb (HP:0001199) | 2.35225988 |
| 54 | Optic disc pallor (HP:0000543) | 2.32391288 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.27888222 |
| 56 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.27385078 |
| 57 | Hypothermia (HP:0002045) | 2.23749799 |
| 58 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.21878261 |
| 59 | Thyroid-stimulating hormone excess (HP:0002925) | 2.20721320 |
| 60 | Partial duplication of thumb phalanx (HP:0009944) | 2.20240240 |
| 61 | Exercise intolerance (HP:0003546) | 2.19947265 |
| 62 | Petechiae (HP:0000967) | 2.19351822 |
| 63 | Hypoplasia of the radius (HP:0002984) | 2.18868623 |
| 64 | Purpura (HP:0000979) | 2.18645125 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.18358903 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.18358903 |
| 67 | Supernumerary spleens (HP:0009799) | 2.18323586 |
| 68 | Partial duplication of the phalanx of hand (HP:0009999) | 2.18184575 |
| 69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.16079800 |
| 70 | Abnormality of complement system (HP:0005339) | 2.15750285 |
| 71 | Nonprogressive disorder (HP:0003680) | 2.14286841 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14172775 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 2.13759956 |
| 74 | Adrenal hypoplasia (HP:0000835) | 2.12598662 |
| 75 | Increased CSF lactate (HP:0002490) | 2.11033468 |
| 76 | Progressive external ophthalmoplegia (HP:0000590) | 2.10704275 |
| 77 | True hermaphroditism (HP:0010459) | 2.08720286 |
| 78 | Respiratory failure (HP:0002878) | 2.07879460 |
| 79 | Microcytic anemia (HP:0001935) | 2.07436234 |
| 80 | Patchy hypopigmentation of hair (HP:0011365) | 2.07427734 |
| 81 | Hyperglycinuria (HP:0003108) | 2.07184901 |
| 82 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.06364444 |
| 83 | Metabolic acidosis (HP:0001942) | 2.06207213 |
| 84 | Conical tooth (HP:0000698) | 2.05709274 |
| 85 | Methylmalonic aciduria (HP:0012120) | 2.04127298 |
| 86 | Joint hemorrhage (HP:0005261) | 2.02837339 |
| 87 | Hypobetalipoproteinemia (HP:0003563) | 2.02767264 |
| 88 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.02723051 |
| 89 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.02723051 |
| 90 | Agammaglobulinemia (HP:0004432) | 2.02565657 |
| 91 | Testicular atrophy (HP:0000029) | 2.02188800 |
| 92 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01912765 |
| 93 | Abnormality of renal resorption (HP:0011038) | 2.01806992 |
| 94 | Opisthotonus (HP:0002179) | 2.01407242 |
| 95 | Aplastic anemia (HP:0001915) | 2.00236382 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.00169533 |
| 97 | Sparse eyelashes (HP:0000653) | 2.00030295 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.99945871 |
| 99 | Vacuolated lymphocytes (HP:0001922) | 1.99767586 |
| 100 | White forelock (HP:0002211) | 1.99645152 |
| 101 | Attenuation of retinal blood vessels (HP:0007843) | 1.98189957 |
| 102 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97561854 |
| 103 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97561854 |
| 104 | Acute encephalopathy (HP:0006846) | 1.97489098 |
| 105 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97485858 |
| 106 | Split foot (HP:0001839) | 1.95698582 |
| 107 | Methylmalonic acidemia (HP:0002912) | 1.95373081 |
| 108 | Nausea (HP:0002018) | 1.94611272 |
| 109 | Delayed CNS myelination (HP:0002188) | 1.94134726 |
| 110 | IgG deficiency (HP:0004315) | 1.93715042 |
| 111 | Prostate neoplasm (HP:0100787) | 1.92694888 |
| 112 | Chronic sinusitis (HP:0011109) | 1.91170871 |
| 113 | Ketosis (HP:0001946) | 1.90688977 |
| 114 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90194031 |
| 115 | Abnormality of alanine metabolism (HP:0010916) | 1.90194031 |
| 116 | Hyperalaninemia (HP:0003348) | 1.90194031 |
| 117 | Beaking of vertebral bodies (HP:0004568) | 1.90137765 |
| 118 | Duplication of thumb phalanx (HP:0009942) | 1.89836615 |
| 119 | Neutropenia (HP:0001875) | 1.89118680 |
| 120 | Congenital sensorineural hearing impairment (HP:0008527) | 1.88425770 |
| 121 | Deep venous thrombosis (HP:0002625) | 1.87734332 |
| 122 | Hyperglycinemia (HP:0002154) | 1.87633480 |
| 123 | Stomatitis (HP:0010280) | 1.87388916 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 1.86950420 |
| 125 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.85100307 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83421547 |
| 127 | Increased serum lactate (HP:0002151) | 1.80845049 |
| 128 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.80168595 |
| 129 | Absent/shortened dynein arms (HP:0200106) | 1.80168595 |
| 130 | Vomiting (HP:0002013) | 1.80032389 |
| 131 | Nasolacrimal duct obstruction (HP:0000579) | 1.79155096 |
| 132 | Abnormality of serum amino acid levels (HP:0003112) | 1.77008482 |
| 133 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.76783281 |
| 134 | Recurrent sinusitis (HP:0011108) | 1.76311722 |
| 135 | Glomerulonephritis (HP:0000099) | 1.75604624 |
| 136 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.74999095 |
| 137 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.74558521 |
| 138 | Respiratory difficulties (HP:0002880) | 1.73797061 |
| 139 | Asplenia (HP:0001746) | 1.72355426 |
| 140 | Absent thumb (HP:0009777) | 1.72225363 |
| 141 | Abnormality of methionine metabolism (HP:0010901) | 1.71308626 |
| 142 | Cerebral edema (HP:0002181) | 1.70747680 |
| 143 | Muscle fiber atrophy (HP:0100295) | 1.70742458 |
| 144 | Bile duct proliferation (HP:0001408) | 1.70565693 |
| 145 | Abnormal biliary tract physiology (HP:0012439) | 1.70565693 |
| 146 | Renal tubular dysfunction (HP:0000124) | 1.70478246 |
| 147 | Abnormality of dental color (HP:0011073) | 1.70392653 |
| 148 | Abnormality of magnesium homeostasis (HP:0004921) | 1.68697039 |
| 149 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.67933999 |
| 150 | Increased muscle lipid content (HP:0009058) | 1.66765098 |
| 151 | Pancytopenia (HP:0001876) | 1.65927717 |
| 152 | Absent septum pellucidum (HP:0001331) | 1.65609201 |
| 153 | Male pseudohermaphroditism (HP:0000037) | 1.64288932 |
| 154 | Anhidrosis (HP:0000970) | 1.64029681 |
| 155 | Hyperphosphaturia (HP:0003109) | 1.62637265 |
| 156 | Abnormality of urine glucose concentration (HP:0011016) | 1.62293608 |
| 157 | Glycosuria (HP:0003076) | 1.62293608 |
| 158 | Lethargy (HP:0001254) | 1.62220891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.77630755 |
| 2 | CASK | 4.22641526 |
| 3 | TLK1 | 3.94759659 |
| 4 | VRK2 | 3.70850836 |
| 5 | STK16 | 3.35426669 |
| 6 | MKNK2 | 3.32867424 |
| 7 | TNIK | 2.60808803 |
| 8 | MUSK | 2.56564218 |
| 9 | MKNK1 | 2.47745907 |
| 10 | PIM2 | 2.45484690 |
| 11 | LIMK1 | 2.36908389 |
| 12 | TESK1 | 2.30197335 |
| 13 | NLK | 2.08611317 |
| 14 | MAP4K1 | 2.03760222 |
| 15 | BLK | 1.89941607 |
| 16 | TAOK3 | 1.86819698 |
| 17 | SRPK1 | 1.83092456 |
| 18 | IRAK4 | 1.76794989 |
| 19 | PBK | 1.75687239 |
| 20 | IRAK3 | 1.71560056 |
| 21 | ARAF | 1.71311218 |
| 22 | FES | 1.65567769 |
| 23 | CLK1 | 1.55069805 |
| 24 | MAPK15 | 1.52199502 |
| 25 | EIF2AK1 | 1.52129427 |
| 26 | ERN1 | 1.47105583 |
| 27 | TEC | 1.44533604 |
| 28 | MAPKAPK3 | 1.41449005 |
| 29 | MAP3K12 | 1.40523078 |
| 30 | YES1 | 1.39856434 |
| 31 | BCKDK | 1.36765027 |
| 32 | BUB1 | 1.35141898 |
| 33 | MAP4K2 | 1.32957429 |
| 34 | VRK1 | 1.28975406 |
| 35 | PRKD2 | 1.28553732 |
| 36 | TYK2 | 1.27454998 |
| 37 | IRAK1 | 1.27185297 |
| 38 | EIF2AK3 | 1.26547684 |
| 39 | TXK | 1.26244258 |
| 40 | GRK6 | 1.25114109 |
| 41 | MST4 | 1.24017206 |
| 42 | TNK2 | 1.23921593 |
| 43 | DYRK3 | 1.22691340 |
| 44 | MAP3K3 | 1.22533935 |
| 45 | JAK3 | 1.20500773 |
| 46 | CDK19 | 1.17380992 |
| 47 | EIF2AK2 | 1.16452387 |
| 48 | GRK1 | 1.14345906 |
| 49 | NUAK1 | 1.10660498 |
| 50 | PASK | 1.07922992 |
| 51 | IRAK2 | 1.05974415 |
| 52 | ILK | 1.05487733 |
| 53 | BMPR1B | 1.04919103 |
| 54 | LRRK2 | 1.03432800 |
| 55 | ADRBK2 | 1.01003870 |
| 56 | MAP2K3 | 1.00600098 |
| 57 | RPS6KB2 | 1.00256853 |
| 58 | EPHA2 | 0.95240316 |
| 59 | GRK7 | 0.94783023 |
| 60 | IKBKB | 0.94720101 |
| 61 | WEE1 | 0.87237862 |
| 62 | KIT | 0.85965850 |
| 63 | NEK1 | 0.85323187 |
| 64 | CSK | 0.83105618 |
| 65 | PRPF4B | 0.82986842 |
| 66 | INSRR | 0.81990737 |
| 67 | FER | 0.81335553 |
| 68 | KDR | 0.81214756 |
| 69 | PIK3CG | 0.81141200 |
| 70 | CSF1R | 0.79274595 |
| 71 | IKBKE | 0.77013070 |
| 72 | MAPKAPK5 | 0.75982884 |
| 73 | PKN1 | 0.75603231 |
| 74 | TAF1 | 0.74885067 |
| 75 | TAOK2 | 0.74400940 |
| 76 | MATK | 0.74181760 |
| 77 | MAP2K2 | 0.73379900 |
| 78 | SYK | 0.72993354 |
| 79 | CDK7 | 0.71654536 |
| 80 | PRKCI | 0.71616994 |
| 81 | MAPK13 | 0.71258720 |
| 82 | FLT3 | 0.71010791 |
| 83 | STK39 | 0.70516621 |
| 84 | MAPK4 | 0.70307310 |
| 85 | TESK2 | 0.70265988 |
| 86 | BTK | 0.70142842 |
| 87 | NEK9 | 0.68229577 |
| 88 | DYRK2 | 0.67240423 |
| 89 | SCYL2 | 0.66610848 |
| 90 | LYN | 0.65874215 |
| 91 | RPS6KA5 | 0.64488583 |
| 92 | OBSCN | 0.63904959 |
| 93 | DAPK3 | 0.63767926 |
| 94 | DYRK1B | 0.62647467 |
| 95 | MAP2K7 | 0.60494349 |
| 96 | MAP3K14 | 0.59820920 |
| 97 | TIE1 | 0.59471592 |
| 98 | CAMK2B | 0.57162151 |
| 99 | MAP3K11 | 0.57033162 |
| 100 | ITK | 0.56390723 |
| 101 | PRKCQ | 0.56063238 |
| 102 | PIM1 | 0.56051447 |
| 103 | TGFBR2 | 0.55285128 |
| 104 | PRKG2 | 0.54024658 |
| 105 | CSNK2A1 | 0.52669107 |
| 106 | CSNK1G1 | 0.51854583 |
| 107 | AURKA | 0.50812697 |
| 108 | CAMK1 | 0.50631889 |
| 109 | STK24 | 0.50405670 |
| 110 | LCK | 0.50252319 |
| 111 | HIPK2 | 0.48897054 |
| 112 | ABL2 | 0.45531669 |
| 113 | CDK8 | 0.45480322 |
| 114 | CDK9 | 0.45440810 |
| 115 | PRKCD | 0.44296092 |
| 116 | NEK6 | 0.43876950 |
| 117 | PAK1 | 0.43789662 |
| 118 | ZAK | 0.42186937 |
| 119 | BMPR2 | 0.41777007 |
| 120 | CSNK2A2 | 0.41726808 |
| 121 | CDK3 | 0.41361243 |
| 122 | NME1 | 0.41305632 |
| 123 | CAMK2G | 0.41041937 |
| 124 | TBK1 | 0.40486035 |
| 125 | PIK3CA | 0.40447054 |
| 126 | MYLK | 0.39663664 |
| 127 | CDC7 | 0.39073529 |
| 128 | ACVR1B | 0.38611573 |
| 129 | MAPK11 | 0.37913945 |
| 130 | CAMK2D | 0.37528572 |
| 131 | MAP3K13 | 0.37450009 |
| 132 | ADRBK1 | 0.36500498 |
| 133 | PRKCA | 0.35795040 |
| 134 | CCNB1 | 0.35078537 |
| 135 | CSNK1A1 | 0.34277487 |
| 136 | AURKB | 0.34092841 |
| 137 | CSNK1G3 | 0.33726346 |
| 138 | GRK5 | 0.32919329 |
| 139 | MAP2K6 | 0.32482910 |
| 140 | RPS6KA6 | 0.30724527 |
| 141 | ZAP70 | 0.30639618 |
| 142 | PINK1 | 0.30506199 |
| 143 | RPS6KL1 | 0.29907629 |
| 144 | RPS6KC1 | 0.29907629 |
| 145 | CHUK | 0.29180329 |
| 146 | IGF1R | 0.26541411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.72474913 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.16987159 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.46026203 |
| 4 | Homologous recombination_Homo sapiens_hsa03440 | 2.26051435 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.14270745 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.06784453 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98607365 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.94033767 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.92591844 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.91544817 |
| 11 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.86961393 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81280365 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.80982245 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.77107663 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71570207 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70739182 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69582595 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66641134 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.62265475 |
| 20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.61440389 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61219921 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59441602 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.57701610 |
| 24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57045299 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52909025 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.51408216 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47697448 |
| 28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46972856 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46902956 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45250914 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.41140608 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.37679077 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36980208 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36351851 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35735857 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31930557 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 1.29537523 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29414174 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27885129 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26688868 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26358762 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25731494 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25593252 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22680960 |
| 45 | Spliceosome_Homo sapiens_hsa03040 | 1.22486572 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20641184 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.19452170 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15405840 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15285580 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.12691552 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11771735 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.11535163 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10521835 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10279880 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 1.10085007 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08053428 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07663108 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 1.06139525 |
| 59 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.05017279 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01179783 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00807679 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.99510740 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97428200 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96376895 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95588962 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94671880 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92388523 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.90947225 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88431286 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87676198 |
| 71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86981744 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83196774 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79693231 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79471923 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78856085 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78762708 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78715598 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.77773010 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76776251 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76576212 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73674084 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71811957 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71483901 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.67792784 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65630772 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65267488 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65182174 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63204062 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62752544 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62232506 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61635998 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61164776 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60740097 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60523209 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60355765 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59189930 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.56518012 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55425691 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.55402741 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55096517 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54143632 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54081004 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53805659 |
| 104 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52806747 |
| 105 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52758404 |
| 106 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52413913 |
| 107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51721243 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50049049 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50031673 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49912875 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45876497 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45787687 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43508338 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41667486 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41083811 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40691866 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39949453 |
| 118 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39940537 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39207532 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.38732583 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.38711813 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37029524 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36224322 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35227070 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34624078 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32150940 |
| 127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31978382 |

